Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Actelis Networks | ASNS | Sep 27, 2024 | 1.40 | -8.50 |
Actinium Pharmaceuticals | ATNM | Sep 27, 2024 | 1.80 | +0.56 |
Active Bear ETF | HDGE | Sep 27, 2024 | 18.52 | -0.69 |
Active U.S. Real Estate Powershares | PSR | Sep 27, 2024 | 97.84 | +0.18 |
Actuate Therapeutics | ACTU | Sep 27, 2024 | 6.27 | 0.00 |
Acuity Brands | AYI | Sep 27, 2024 | 270.00 | +0.10 |
Acumen Pharmaceuticals | ABOS | Sep 27, 2024 | 2.48 | +2.06 |
Acurx Pharmaceuticals | ACXP | Sep 27, 2024 | 1.92 | -2.54 |
Acushnet | GOLF | Sep 27, 2024 | 64.16 | +0.31 |
ACV Auctions A | ACVA | Sep 27, 2024 | 20.46 | -1.35 |
ACWI Ex-US Index MSCI Ishares | ACWX | Sep 27, 2024 | 57.56 | -0.43 |
ACWI Index MSCI Ishares | ACWI | Sep 27, 2024 | 119.56 | -0.23 |
Adagene ADR | ADAG | Sep 27, 2024 | 2.24 | -0.08 |
Adagio Medical | ADGM | Sep 27, 2024 | 2.86 | 0.00 |
Adams Diversified Equity Fund | ADX | Sep 27, 2024 | 21.39 | +0.09 |
Adams Natural Resources Fund | PEO | Sep 27, 2024 | 23.16 | +1.62 |
Adams Resources & Energy | AE | Sep 27, 2024 | 25.65 | -1.23 |
AdaptHealth | AHCO | Sep 27, 2024 | 11.13 | +8.06 |
Adaptimmune Therapeutics ADR | ADAP | Sep 27, 2024 | 0.98 | +4.29 |
Adaptive Biotechnologies | ADPT | Sep 27, 2024 | 5.00 | +2.04 |
ADC Therapeutics SA | ADCT | Sep 27, 2024 | 3.08 | +2.67 |
Addentax Group | ATXG | Sep 27, 2024 | 0.65 | +4.22 |
Addex Therapeutics ADR | ADXN | Sep 27, 2024 | 9.05 | -6.02 |
Addus HomeCare | ADUS | Sep 27, 2024 | 130.95 | -0.67 |
Adecoagro | AGRO | Sep 27, 2024 | 11.37 | -2.07 |
Adeia | ADEA | Sep 27, 2024 | 11.93 | -0.25 |
Adial Pharmaceuticals | ADIL | Sep 27, 2024 | 1.01 | +0.97 |
Adicet Bio | ACET | Sep 27, 2024 | 1.43 | +2.14 |
Adient | ADNT | Sep 27, 2024 | 23.70 | +3.49 |
Aditxt | ADTX | Sep 27, 2024 | 0.16 | -25.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.